These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22460631)

  • 21. Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study.
    Yang B; Shan J; Feng Y; Dai N; Li M; Chen C; He S; Wang G; Xiao H; Li C; Wang D
    Radiat Oncol; 2020 May; 15(1):94. PubMed ID: 32375814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Kim E; Kim K; Kim SH; Han SW; Kim TY; Jeong SY; Park KJ; Koh J; Kang GH; Chie EK
    Cancer Res Treat; 2019 Jul; 51(3):1188-1197. PubMed ID: 30590006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer.
    Ma B; Xu Q; Song Y; Gao P; Wang Z
    Future Oncol; 2017 Nov; 13(27):2489-2501. PubMed ID: 29124955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study.
    Bertocchi E; Barugola G; Nicosia L; Mazzola R; Ricchetti F; Dell'Abate P; Alongi F; Ruffo G
    Radiol Med; 2020 Oct; 125(10):990-998. PubMed ID: 32277332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?
    Rödel C; Trojan J; Bechstein WO; Woeste G
    Dig Dis; 2012; 30 Suppl 2():102-8. PubMed ID: 23207941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
    Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results.
    Jang KM; Kim SH; Choi D; Lee SJ; Park MJ; Min K
    Br J Radiol; 2012 Sep; 85(1017):e566-72. PubMed ID: 22422387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.
    McCarthy K; Pearson K; Fulton R; Hewitt J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008368. PubMed ID: 23235660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
    Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
    Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
    Gollins S
    Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
    Perez RO; Habr-Gama A; Gama-Rodrigues J; Proscurshim I; Julião GP; Lynn P; Ono CR; Campos FG; Silva e Sousa AH; Imperiale AR; Nahas SC; Buchpiguel CA
    Cancer; 2012 Jul; 118(14):3501-11. PubMed ID: 22086847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.
    MacGregor TP; Maughan TS; Sharma RA
    J Clin Pathol; 2012 Oct; 65(10):867-71. PubMed ID: 22734005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
    Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Ramsay RG; Phillips WA; Heriot AG
    Colorectal Dis; 2016 Mar; 18(3):234-46. PubMed ID: 26531759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving Treatment Paradigm in the Treatment of Locally Advanced Rectal Cancer.
    Smith CA; Kachnic LA
    J Natl Compr Canc Netw; 2018 Jul; 16(7):909-915. PubMed ID: 30006431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Novel Agents with Radiotherapy to Treat Rectal Cancer.
    Greenhalgh TA; Dearman C; Sharma RA
    Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):116-139. PubMed ID: 26719097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences.
    Seo N; Kim H; Cho MS; Lim JS
    Korean J Radiol; 2019 Jul; 20(7):1003-1018. PubMed ID: 31270972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.